Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00081627
What this trial is testing

Clinical Trial in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Mast Therapeutics, Inc. 48
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07542262
What this trial is testing

Low-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR Cancers

Who this might be right for
Colorectal CancerGastric Cancer
Blokhin's Russian Cancer Research Center 128
Early research (Phase 1)WithdrawnNCT00960427
What this trial is testing

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT03561142
What this trial is testing

Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy.

Who this might be right for
Rectal CancerRectal NeoplasmsRectal Cancer Stage II+1 more
University Hospital Tuebingen 94
Testing effectiveness (Phase 2)Study completedNCT01225744
What this trial is testing

Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy

Who this might be right for
Metastatic Colorectal Cancer
The Christie NHS Foundation Trust 47
Testing effectiveness (Phase 2)Study completedNCT03854799
What this trial is testing

Immunotherapy In Locally Advanced Rectal Cancer

Who this might be right for
Colon Rectal Cancer
Gruppo Oncologico del Nord-Ovest 101
Testing effectiveness (Phase 2)Temporarily pausedNCT01723306
What this trial is testing

Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

Who this might be right for
Metastatic Cancers
Roger Williams Medical Center 48
Testing effectiveness (Phase 2)Ended earlyNCT05039944
What this trial is testing

SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies

Who this might be right for
Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT00569699
What this trial is testing

Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)

Who this might be right for
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd. 56
Testing effectiveness (Phase 2)Study completedNCT00077298
What this trial is testing

Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT02219893
What this trial is testing

Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa Trial

Who this might be right for
Colorectal Neoplasms
Oslo University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00875771
What this trial is testing

Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 80
Testing effectiveness (Phase 2)Study completedNCT03122509
What this trial is testing

A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Memorial Sloan Kettering Cancer Center 25
Not applicableActive Not RecruitingNCT04832763
What this trial is testing

Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal Cancer

Who this might be right for
Stage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage IIA Colorectal Cancer AJCC v8+10 more
University of Southern California 32
Testing effectiveness (Phase 2)Study completedNCT01417494
What this trial is testing

1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 102
Testing effectiveness (Phase 2)Study completedNCT04907539
What this trial is testing

Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC)

Who this might be right for
Colorectal Cancer
Redx Pharma Ltd 25
Not applicableStudy completedNCT04597151
What this trial is testing

Diet Education Program for Stage I-IV Colorectal Cancer Survivors

Who this might be right for
Stage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage IIA Colorectal Cancer AJCC v8+10 more
University of California, San Francisco 13
Testing effectiveness (Phase 2)Looking for participantsNCT07095439
What this trial is testing

Efficacy and Toxicity of Total Neoadjuvant Sandwich Treatment Via Short Course Radiotherapy in the Treatment of Stage II and III Rectal Cancer Patients

Who this might be right for
Rectal Cancer
Ain Shams University 38
Testing effectiveness (Phase 2)Looking for participantsNCT06856837
What this trial is testing

- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

Who this might be right for
Metastatic Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 140
Testing effectiveness (Phase 2)UnknownNCT01144195
What this trial is testing

A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy

Who this might be right for
Metastatic Colorectal Cancer
Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials 80
Next Page